-
Mashup Score: 13 trends to watch in biotech in 2024 - 4 month(s) ago
After two years of steady decline in biotech, industry optimists might be onto something heading into 2024.
Source: www.statnews.comCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 17The Age of Crispr Medicine Is Here - 4 month(s) ago
The approval of the first Crispr-based therapy is just the beginning. Getting it to patients is the next hurdle.
Source: www.wired.comCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 11AbbVie to Acquire Cerevel Therapeutics in Transformative Transaction to Strengthen Neuroscience Pipeline - 5 month(s) ago
Proposed acquisition adds robust pipeline of assets focused on best-in-class potential for psychiatric and neurological disorders where significant unmet needs remain Cerevel’s clinical-stage…
Source: news.abbvie.comCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 1
Camille Bedrosian → With Amylyx Pharmaceuticals’ ALS drug in full commercial swing, the Massachusetts startup has found a replacement for its chief medical officer. Camille Bedrosian will join the company from Ultragenyx, taking the place […]
Source: sfbn.orgCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 1Candor on gene therapy, Abiomed is warned, & BTK success in MS - 7 month(s) ago
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Good morning! Today, cell and
Source: www.statnews.comCategories: General Medicine News, Latest HeadlinesTweet
-
Mashup Score: 1UC San Diego and Mount Sinai Receive $8.5M NIH Award for Data Integration Hub – San Diego Biotechnology Network - 7 month(s) ago
Researchers at UC San Diego and the Icahn School of Medicine at Mount Sinai have been awarded an $8.5 million grant to create a data integration hub aimed at accelerating novel therapeutics and cures for diseases within initiatives supported by the NIH Common … Click here to view original
Source: sdbn.orgCategories: Future of Medicine, Latest HeadlinesTweet
-
Mashup Score: 0Pharmalittle: Novo faces patent challenge on Wegovy and Ozempic; Senate panel moves to address drug shortages - 7 month(s) ago
A U.S. Patent Office tribunal agreed to review the validity of a Novo Nordisk patent related to its blockbuster drugs Ozempic and Wegovy.
Source: www.statnews.comCategories: General Medicine News, Latest HeadlinesTweet
-
Mashup Score: 0
Some analysts are questioning whether Amgen was fully forthcoming about a pricey lung cancer drug that is supposed to generate key revenue growth.
Source: www.statnews.comCategories: General Medicine News, Latest HeadlinesTweet
-
Mashup Score: 0Marketing platform Doceree secures $35M and more digital health - 7 month(s) ago
CellFE, a tech-enabled cell engineering platform, and Plenful, a workflow-automation platform for pharmacy operations, also garnered investment.
Source: www.mobihealthnews.comCategories: Healthcare Professionals, Latest HeadlinesTweet
-
Mashup Score: 1Q3 snapshot: The IPO market shows fresh signs of improvement, but the biotech crunch continues to bite - 7 month(s) ago
The biotech IPO market crashed hard last year, but we’re seeing the window creak open in a steady upward trend in 2023 that bodes for better times — though it’s a long, long way from a boom. Chris Dokomajilar at DealForma is back crunching the numbers, and we’ll start with
Source: endpts.comCategories: Healthcare Professionals, Latest HeadlinesTweet
.@damiangarde brings you three major #biotech themes that will drive the news in 2024: https://t.co/CTg8punYTb